PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set

Acta Oncologica 2026 Open access

Read full text
Authors: Maja B Drakenberg Danese, Christoffer Vannas, Henrik A Fagman, Per Olof Karlsson, Karolina Fs Larsson
DOI: 10.2340/1651-226x.2026.45589
Cited by: 1
References: 25

Fields of Study & Subjects

PI3K/AKT/mTOR signaling in cancer Metabolism Diabetes and Cancer Advanced Breast Cancer Therapies

Publication details

Journal / source
Acta Oncologica
Publisher
MJS Publishing, Medical Journals Sweden AB
Volume
65
Pages
401–405
Publication date
11 May 2026
Language
EN